222 related articles for article (PubMed ID: 26124218)
1. Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer.
Ren JG; Man QW; Zhang W; Li C; Xiong XP; Zhu JY; Wang WM; Sun ZJ; Jia J; Zhang WF; Zhao YF; Chen G; Liu B
J Dent Res; 2016 Jan; 95(1):87-93. PubMed ID: 26124218
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance and Roles in Angiogenesis of Circulating Microparticles in Oral Cancer.
Ren JG; Zhang W; Liu B; Man QW; Xiong XP; Li C; Zhu JY; Wang WM; Jia J; Sun ZJ; Zhang WF; Chen G; Zhao YF
J Dent Res; 2016 Jul; 95(8):860-7. PubMed ID: 27013642
[TBL] [Abstract][Full Text] [Related]
3. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
[TBL] [Abstract][Full Text] [Related]
4. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
5. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer.
Haghbin M; Hashemi Tayer A; Kamravan M; Sotoodeh Jahromi A
Asian Pac J Cancer Prev; 2021 May; 22(5):1573-1579. PubMed ID: 34048188
[TBL] [Abstract][Full Text] [Related]
6. Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.
Burbano C; Villar-Vesga J; Orejuela J; Muñoz C; Vanegas A; Vásquez G; Rojas M; Castaño D
Front Immunol; 2018; 9():322. PubMed ID: 29545790
[TBL] [Abstract][Full Text] [Related]
7. Involvement of platelet-derived microparticles in tumor progression and thrombosis.
Mezouar S; Mege D; Darbousset R; Farge D; Debourdeau P; Dignat-George F; Panicot-Dubois L; Dubois C
Semin Oncol; 2014 Jun; 41(3):346-58. PubMed ID: 25023350
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
9. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
Zhao L; Bi Y; Kou J; Shi J; Piao D
J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
14. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
[TBL] [Abstract][Full Text] [Related]
15. Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles.
Liu T; Wang J; Li T; Cui P; Hou B; Zhuang C; Wei G; Zhang S; Li H; Hu Y
BMC Cancer; 2021 Aug; 21(1):939. PubMed ID: 34416874
[TBL] [Abstract][Full Text] [Related]
16. Endogenous microparticles drive the proinflammatory host immune response in severely injured trauma patients.
Balvers K; Curry N; Kleinveld DJ; Böing AN; Nieuwland R; Goslings JC; Juffermans NP
Shock; 2015 Apr; 43(4):317-21. PubMed ID: 25565646
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
Liang YJ; Mei XY; Zeng B; Zhang SE; Yang L; Lao XM; Liao GQ
BMC Cancer; 2021 Feb; 21(1):122. PubMed ID: 33546637
[TBL] [Abstract][Full Text] [Related]
18. A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.
Niccolai E; Squatrito D; Emmi G; Silvestri E; Emmi L; Ciucciarelli L; Ricci F; Manganaro D; Amedei A; Prisco D
Thromb Res; 2015 Dec; 136(6):1252-8. PubMed ID: 26476741
[TBL] [Abstract][Full Text] [Related]
19.
Nijiati M; Saidaming A; Guoqing L
Ann Clin Lab Sci; 2017 Mar; 47(2):156-161. PubMed ID: 28442516
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of microparticles in whole blood by multicolour flow cytometry assay.
Christersson C; Johnell M; Siegbahn A
Scand J Clin Lab Invest; 2013 Apr; 73(3):229-39. PubMed ID: 23452203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
